2024-09-06 - Analysis Report
## Lilly (LLY) Stock Analysis Report

This report analyzes Lilly (LLY), a leading pharmaceutical company known for its diverse portfolio of medicines across various therapeutic areas, including diabetes, oncology, and immunology.

**1. Performance vs. S&P 500:**

* **Cumulative return (LLY):** 566.13%
* **Cumulative return (VOO):** 85.32%
* **Difference:** 480.81%
* **Relative divergence:** 99.71% (indicates that LLY has outperformed the S&P 500 by a significant margin historically)

**2. Recent Price Movements:**

* **Closing price:** $956.53
* **5-day moving average:** $952.03
* **20-day moving average:** $916.07
* **60-day moving average:** $890.72 

This suggests a recent upward trend in the stock price, with the price currently trading above all three moving averages.

**3. Technical Indicators:**

* **RSI (71.83):** Indicates the stock is currently in overbought territory, potentially suggesting a short-term correction may be on the horizon. 
* **PPO (0.25):**  A positive value suggests a bullish momentum.
* **Delta_Previous_Relative_Divergence (21.69):** Indicates a recent surge in the stock's price relative to its historical performance.
* **Expected_Return (1.4%):** This represents an estimated 5-year return on investment for a lump sum investment.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-08 | 3.29 | 11.30 B$ |
| 2024-04-30 | 2.49 | 8.77 B$ |
| 2023-11-02 | -0.06 | 9.50 B$ |
| 2023-08-08 | 1.96 | 8.31 B$ |
| 2023-05-04 | 1.96 | 8.31 B$ |

* **Most recent earnings (2024-08-08):**  The company exceeded analysts' expectations, reporting strong EPS and revenue growth. This positive performance reflects the company's continued success in its core markets. 

**5. Summary:**

Lilly has historically outperformed the broader market, exhibiting strong growth. The company's recent financial results have been positive, exceeding expectations and demonstrating continued momentum. Technical indicators suggest an overbought situation, hinting at potential short-term correction. Nevertheless, the company's strong fundamentals, diverse portfolio, and positive future outlook make it a compelling investment option for long-term investors. 

**6. Important Disclaimers:**

This report is for informational purposes only and does not constitute investment advice. The information presented is based on publicly available data and should not be considered a recommendation to buy or sell any securities. Investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions. 
